FI104362B - Menetelmä uutteen valmistamiseksi cucurbita sp. -kasvin siemenistä - Google Patents

Menetelmä uutteen valmistamiseksi cucurbita sp. -kasvin siemenistä Download PDF

Info

Publication number: FI104362B
Authority: FI; Finland
Prior art keywords: cucurbita; carbon dioxide; bar; extracts; seeds
Prior art date: 1992-12-09

Application number

FI935499A

Other languages

English (en)

Finnish (fi)

Swedish (sv)

Other versions

FI935499L (fi

FI935499A0 (fi

Inventor

Ezio Bombardelli

Original Assignee

Indena Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-12-09

Filing date

1993-12-08

Publication date

2000-01-14

1993-12-08 Application filed by Indena Spa filed Critical Indena Spa

1993-12-08 Publication of FI935499A0 publication Critical patent/FI935499A0/fi

1994-06-10 Publication of FI935499L publication Critical patent/FI935499L/fi

2000-01-14 Application granted granted Critical

2000-01-14 Publication of FI104362B publication Critical patent/FI104362B/fi

Links

239000000284 extract Substances 0.000 title claims abstract description 49
241000219122 Cucurbita Species 0.000 title claims abstract description 18
238000000034 method Methods 0.000 title claims abstract description 14
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims abstract description 38
238000000605 extraction Methods 0.000 claims abstract description 27
229910002092 carbon dioxide Inorganic materials 0.000 claims abstract description 19
239000001569 carbon dioxide Substances 0.000 claims abstract description 18
238000002360 preparation method Methods 0.000 claims abstract description 7
239000013543 active substance Substances 0.000 claims abstract description 5
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 11
239000002904 solvent Substances 0.000 claims description 10
-1 aliphatic alcohols Chemical class 0.000 claims description 4
125000001931 aliphatic group Chemical group 0.000 claims description 4
229910052799 carbon Inorganic materials 0.000 claims description 3
238000000227 grinding Methods 0.000 claims description 3
239000004480 active ingredient Substances 0.000 claims description 2
238000009835 boiling Methods 0.000 claims description 2
239000002245 particle Substances 0.000 claims description 2
240000001980 Cucurbita pepo Species 0.000 abstract description 8
210000002307 prostate Anatomy 0.000 abstract description 8
235000009852 Cucurbita pepo Nutrition 0.000 abstract description 7
239000002537 cosmetic Substances 0.000 abstract description 5
208000002874 Acne Vulgaris Diseases 0.000 abstract description 3
206010000496 acne Diseases 0.000 abstract description 3
230000000366 juvenile effect Effects 0.000 abstract description 2
238000003801 milling Methods 0.000 abstract description 2
239000003960 organic solvent Substances 0.000 abstract description 2
206010020880 Hypertrophy Diseases 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
238000000746 purification Methods 0.000 abstract 1
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 24
239000003921 oil Substances 0.000 description 21
235000019198 oils Nutrition 0.000 description 21
230000000694 effects Effects 0.000 description 11
241000196324 Embryophyta Species 0.000 description 10
229930182558 Sterol Natural products 0.000 description 7
238000007127 saponification reaction Methods 0.000 description 7
150000003432 sterols Chemical class 0.000 description 7
235000003702 sterols Nutrition 0.000 description 7
239000002253 acid Substances 0.000 description 5
239000007789 gas Substances 0.000 description 5
239000000463 material Substances 0.000 description 5
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
206010004446 Benign prostatic hyperplasia Diseases 0.000 description 4
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
208000004403 Prostatic Hyperplasia Diseases 0.000 description 4
MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 4
235000014113 dietary fatty acids Nutrition 0.000 description 4
229930195729 fatty acid Natural products 0.000 description 4
239000000194 fatty acid Substances 0.000 description 4
150000004665 fatty acids Chemical class 0.000 description 4
239000007903 gelatin capsule Substances 0.000 description 4
239000011630 iodine Substances 0.000 description 4
229910052740 iodine Inorganic materials 0.000 description 4
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
230000001548 androgenic effect Effects 0.000 description 3
238000001035 drying Methods 0.000 description 3
239000007788 liquid Substances 0.000 description 3
239000000825 pharmaceutical preparation Substances 0.000 description 3
230000000144 pharmacologic effect Effects 0.000 description 3
239000000126 substance Substances 0.000 description 3
230000001225 therapeutic effect Effects 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
241000700159 Rattus Species 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
229960003473 androstanolone Drugs 0.000 description 2
230000008485 antagonism Effects 0.000 description 2
239000012298 atmosphere Substances 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
239000003925 fat Substances 0.000 description 2
235000019197 fats Nutrition 0.000 description 2
238000001030 gas--liquid chromatography Methods 0.000 description 2
150000008131 glucosides Chemical group 0.000 description 2
206010020718 hyperplasia Diseases 0.000 description 2
239000004615 ingredient Substances 0.000 description 2
239000002207 metabolite Substances 0.000 description 2
239000000203 mixture Substances 0.000 description 2
239000012299 nitrogen atmosphere Substances 0.000 description 2
238000000926 separation method Methods 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
229960003604 testosterone Drugs 0.000 description 2
239000004408 titanium dioxide Substances 0.000 description 2
SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
238000001157 Fourier transform infrared spectrum Methods 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
238000012404 In vitro experiment Methods 0.000 description 1
239000005909 Kieselgur Substances 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
206010036018 Pollakiuria Diseases 0.000 description 1
206010039792 Seborrhoea Diseases 0.000 description 1
BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
240000008042 Zea mays Species 0.000 description 1
235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
235000002017 Zea mays subsp mays Nutrition 0.000 description 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000007059 acute toxicity Effects 0.000 description 1
231100000403 acute toxicity Toxicity 0.000 description 1
239000003463 adsorbent Substances 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
230000003110 anti-inflammatory effect Effects 0.000 description 1
230000003431 anti-prostaglandin Effects 0.000 description 1
239000000043 antiallergic agent Substances 0.000 description 1
OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
235000014121 butter Nutrition 0.000 description 1
239000002775 capsule Substances 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
238000004140 cleaning Methods 0.000 description 1
230000006835 compression Effects 0.000 description 1
238000007906 compression Methods 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
239000000470 constituent Substances 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
238000001816 cooling Methods 0.000 description 1
230000001086 cytosolic effect Effects 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
238000004821 distillation Methods 0.000 description 1
238000009826 distribution Methods 0.000 description 1
239000003814 drug Substances 0.000 description 1
206010013990 dysuria Diseases 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
229940043351 ethyl-p-hydroxybenzoate Drugs 0.000 description 1
NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
ZSRQDUNHUIEDHK-UHFFFAOYSA-N excelsioside Natural products COC(=O)C1=COC(OC2OC(CO)C(O)C(O)C2O)C(=CC)C1CC(=O)Oc3ccc(CCO)cc3 ZSRQDUNHUIEDHK-UHFFFAOYSA-N 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
VTSMBFKSVVGHBS-UHFFFAOYSA-N formoside Natural products C1CC2(C)C(C(CCC=C(C)C)C)CCC2(C(O)=O)C(CCC2C3(C)C)=C1C2(C)CCC3OC(C1OC2C(C(O)C(O)C(CO)O2)O)OCC(O)C1OC(C1O)OCC(O)C1OC1OC(CO)C(O)C(O)C1O VTSMBFKSVVGHBS-UHFFFAOYSA-N 0.000 description 1
238000005194 fractionation Methods 0.000 description 1
235000021588 free fatty acids Nutrition 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
230000000762 glandular Effects 0.000 description 1
229930182478 glucoside Natural products 0.000 description 1
125000005456 glyceride group Chemical group 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
239000011261 inert gas Substances 0.000 description 1
238000002329 infrared spectrum Methods 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
230000002045 lasting effect Effects 0.000 description 1
238000002386 leaching Methods 0.000 description 1
235000009973 maize Nutrition 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
238000004949 mass spectrometry Methods 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
238000012261 overproduction Methods 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
229940127557 pharmaceutical product Drugs 0.000 description 1
230000003285 pharmacodynamic effect Effects 0.000 description 1
238000009160 phytotherapy Methods 0.000 description 1
208000017497 prostate disease Diseases 0.000 description 1
238000010992 reflux Methods 0.000 description 1
238000012216 screening Methods 0.000 description 1
208000008742 seborrheic dermatitis Diseases 0.000 description 1
229910052711 selenium Inorganic materials 0.000 description 1
239000011669 selenium Substances 0.000 description 1
KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
208000017520 skin disease Diseases 0.000 description 1
239000000344 soap Substances 0.000 description 1
238000000638 solvent extraction Methods 0.000 description 1
241000894007 species Species 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
238000003756 stirring Methods 0.000 description 1
239000000829 suppository Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
239000003826 tablet Substances 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
239000011573 trace mineral Substances 0.000 description 1
235000013619 trace mineral Nutrition 0.000 description 1
238000011144 upstream manufacturing Methods 0.000 description 1
230000002485 urinary effect Effects 0.000 description 1
208000022934 urinary frequency Diseases 0.000 description 1
230000036318 urination frequency Effects 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
239000005418 vegetable material Substances 0.000 description 1
238000009423 ventilation Methods 0.000 description 1
239000011701 zinc Substances 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1

Classifications

- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/0203—Solvent extraction of solids with a supercritical fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/008—Preparations for oily hair
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Natural Medicines & Medicinal Plants (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Botany (AREA)
Biotechnology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Birds (AREA)
Chemical Kinetics & Catalysis (AREA)
Dermatology (AREA)
Medical Informatics (AREA)
Alternative & Traditional Medicine (AREA)
Organic Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Urology & Nephrology (AREA)
Medicines Containing Plant Substances (AREA)
Cosmetics (AREA)
Fats And Perfumes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

FI935499A 1992-12-09 1993-12-08 Menetelmä uutteen valmistamiseksi cucurbita sp. -kasvin siemenistä FI104362B (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE4241487A DE4241487C2 (de)	1992-12-09	1992-12-09	Neue Extrakte von Cucurbita sp., Verfahren zu deren Herstellung und deren Verwendung in Arzneimitteln und in der Kosmetik
DE4241487		1992-12-09

Publications (3)

Publication Number	Publication Date
FI935499A0 FI935499A0 (fi)	1993-12-08
FI935499L FI935499L (fi)	1994-06-10
FI104362B true FI104362B (fi)	2000-01-14

Family

ID=6474800

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI935499A FI104362B (fi)	1992-12-09	1993-12-08	Menetelmä uutteen valmistamiseksi cucurbita sp. -kasvin siemenistä

Country Status (13)

Country	Link
US (1)	US5547673A (da)
JP (1)	JP2912537B2 (da)
KR (1)	KR100188572B1 (da)
AU (1)	AU674710B2 (da)
CA (1)	CA2111036C (da)
DE (1)	DE4241487C2 (da)
DK (1)	DK176155B1 (da)
FI (1)	FI104362B (da)
FR (1)	FR2698791B1 (da)
GB (1)	GB2273442B (da)
IT (1)	IT1265258B1 (da)
NO (1)	NO307866B1 (da)
SE (1)	SE506496C2 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6379714B1 (en)	1995-04-14	2002-04-30	Pharmaprint, Inc.	Pharmaceutical grade botanical drugs
DE69711025T2 (de) *	1997-05-15	2002-08-22	Societe Des Produits Nestle S.A., Vevey	Verfahren zur Herstellung und Extraktion von Aromas
US6111108A (en) *	1997-07-01	2000-08-29	Midwest Research Institute	Extraction of biologically active components from Camptotheca acuminata with supercritical fluids
ES2297934T3 (es)	1998-08-03	2008-05-01	Ronald E. Wheeler	Formula prostatica.
US6241987B1 (en) *	1998-08-20	2001-06-05	Amway Corporation	Dietary supplement containing saw palmetto, pumpkin seed, and nettle root
KR100546735B1 (ko) *	1998-09-23	2006-04-20	주식회사 엘지생활건강	피부미백제 조성물
FR2786778A1 (fr) *	1998-12-04	2000-06-09	Soldive	Extrait placentaire de fruit, procede de preparation et composition le contenant
US6117431A (en) *	1999-12-03	2000-09-12	Pharmline Inc.	Method for obtaining an extract from ginkgo biloba leaves
RU2197977C2 (ru) *	2001-04-17	2003-02-10	Дмитриенко Николай Васильевич	Масло семян тыквы, обладающее противовоспалительным, противоязвенным и гепатопротекторным действием, и способ его получения
FR2832418B1 (fr) *	2001-11-16	2005-06-24	Fabre Pierre Dermo Cosmetique	Procede de preparation d'une huile de courge hydrolysee, l'huile de courge hydrolysee susceptible d'etre obtenue par ce procede et son utilisation
JP2004002217A (ja) *	2002-05-31	2004-01-08	Noevir Co Ltd	皮膚外用剤
KR100511222B1 (ko) *	2002-06-05	2005-08-31	유앤아이화장품(주)	동아 추출물을 함유하는 여드름 피부용 화장료 조성물과그의 제조방법
KR100627618B1 (ko)	2004-08-23	2006-09-25	최성애	곡류 또는 씨앗을 이용한 기능성 물질 추출방법
MY146635A (en) *	2004-09-01	2012-09-14	Malaysian Palm Oil Board	Specialty palm oil products and other specialty vegetable oil products
FR2874503B1 (fr) *	2004-09-01	2006-11-24	Soc Ind Limousine Dapplication Biologique Silab	Procede d'obtention d'un principe actif raffermissant et a visee anti-vergetures, actif obtenu et les fonctionnalites
JP4630102B2 (ja) *	2005-03-30	2011-02-09	株式会社ナリス化粧品	ヒアルロン酸産生促進剤、及びこれを含有する化粧料
DE102005017407A1 (de)	2005-04-15	2006-10-19	Degussa Ag	Verfahren zur Behandlung von natürlichen Ausgangsmaterialien mit Hilfe verdichteter Gase
ES2345396T3 (es) *	2006-02-10	2010-09-22	Carotech Sdn. Bhd	Proceso para la produccion de fracciones altamente enriquecidas de compuestos naturales de aceite de palma con fluidos supercriticos y proximos al estado critico.
GB0712972D0 (en) *	2007-07-04	2007-08-15	Glaxosmithkline Consumer Healt	Formulation
MY162712A (en) *	2008-12-04	2017-07-14	Univ Putra Malaysia	A supercritical fluid extraction process of kenaf seeds
DE102010031263A1 (de)	2009-07-10	2011-03-03	Hohenester, Hermann, Dr.	Zubereitung enthaltend Zucchini und/oder Ingwer und/oder Papaya und/oder Ananas zur Behandlung von Körperteilen bzw. zur kosmetischen Pflege und insbesondere zur Mundpflege
JP5809470B2 (ja) *	2011-07-25	2015-11-11	株式会社ファンケル	玄米由来の植物性ステロール配糖体の製造方法
AU2012302146A1 (en) *	2011-09-02	2014-04-03	Burt's Farm, LLC	Personal care compositions comprising squash or pumpkin extract
FR2992859B1 (fr) *	2012-07-09	2014-10-03	Fabre Pierre Dermo Cosmetique	Utilisation de coceth sulfate de zinc comme agent antibacterien vis a vis de propionibacterium acnes
US10405795B1 (en)	2013-03-15	2019-09-10	The Procter & Gamble Company	Methods of classifying periorbital dyschromia and systems therefor
US20170296457A1 (en) *	2016-04-14	2017-10-19	The Procter & Gamble Company	Products and methods for treating periorbital dyschromia
CN106619785A (zh) *	2016-10-21	2017-05-10	黑龙江省云会生物科技有限公司	一种改善尿频及尿失禁的药品或者食品及制备方法
CN107389845B (zh) *	2017-09-04	2019-10-01	黑龙江大学	一种南瓜子的高效液相色谱指纹图谱的建立方法及其标准指纹图谱

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4255418A (en) *	1979-05-14	1981-03-10	Bailey Florence H	Anti-acne lotion
DE3067048D1 (en) *	1979-12-03	1984-04-19	Kitasato Inst	A process for preparing substances having interferon inducing activity and interferon inducers
FR2522500A1 (fr) *	1982-03-02	1983-09-09	Rougereau Andre	Medicament et cosmetique a base de potiron
US4495207A (en) *	1982-10-25	1985-01-22	The United States Of America As Represented By The Secretary Of Agriculture	Production of food-grade corn germ product by supercritical fluid extraction
DE3322968A1 (de) *	1983-06-25	1985-01-10	Fried. Krupp Gmbh, 4300 Essen	Verfahren und vorrichtung zur gewinnung von fetten und oelen
US4692280A (en) *	1986-12-01	1987-09-08	The United States Of America As Represented By The Secretary Of Commerce	Purification of fish oils
US4820537A (en) *	1987-03-13	1989-04-11	General Foods Corporation	Method for decaffeinating coffee with a supercritical fluid
US4996317A (en) *	1988-08-05	1991-02-26	Kraft General Foods, Inc.	Caffeine recovery from supercritical carbon dioxide
US5124313A (en) *	1989-06-02	1992-06-23	Schaeffer Hans A	Methods of improved skin care and the treatment of dermatological conditions
US5104587A (en) *	1990-05-16	1992-04-14	The Procter & Gamble Company	Countercurrent liquid/liquid extraction to fractionate complex mixtures containing medium and long chain fatty acid triglycerides
PH11992043811B1 (en) *	1991-01-24	2002-08-22	Martek Corp	Arachidonic acid and methods for the production and use thereof
FR2673375A1 (fr) *	1991-02-28	1992-09-04	Dior Christian Parfums	Utilisation de la cucurbitine pour la preparation d'une composition cosmetique ou pharmaceutique, notamment dermatologique, anti-allergique, et procede en comportant application.

1992
- 1992-12-09 DE DE4241487A patent/DE4241487C2/de not_active Expired - Fee Related
1993
- 1993-12-06 IT IT93MI002571A patent/IT1265258B1/it active IP Right Grant
- 1993-12-08 SE SE9304080A patent/SE506496C2/sv not_active IP Right Cessation
- 1993-12-08 AU AU52297/93A patent/AU674710B2/en not_active Ceased
- 1993-12-08 US US08/162,764 patent/US5547673A/en not_active Expired - Lifetime
- 1993-12-08 NO NO934472A patent/NO307866B1/no not_active IP Right Cessation
- 1993-12-08 JP JP5340211A patent/JP2912537B2/ja not_active Expired - Fee Related
- 1993-12-08 CA CA002111036A patent/CA2111036C/en not_active Expired - Fee Related
- 1993-12-08 FI FI935499A patent/FI104362B/fi not_active IP Right Cessation
- 1993-12-08 GB GB9325172A patent/GB2273442B/en not_active Expired - Fee Related
- 1993-12-09 DK DK199301377A patent/DK176155B1/da not_active IP Right Cessation
- 1993-12-09 FR FR9314808A patent/FR2698791B1/fr not_active Expired - Fee Related
- 1993-12-09 KR KR1019930027079A patent/KR100188572B1/ko not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ITMI932571A1 (it)	1995-06-06
JPH06234648A (ja)	1994-08-23
DK137793D0 (da)	1993-12-09
GB9325172D0 (en)	1994-02-09
FR2698791A1 (fr)	1994-06-10
DK137793A (da)	1994-06-10
US5547673A (en)	1996-08-20
FI935499L (fi)	1994-06-10
NO934472L (no)	1994-06-10
NO307866B1 (no)	2000-06-13
DE4241487A1 (de)	1994-06-16
DE4241487C2 (de)	1996-07-25
CA2111036C (en)	2000-08-01
KR940013528A (ko)	1994-07-15
DK176155B1 (da)	2006-10-23
ITMI932571A0 (it)	1993-12-06
AU5229793A (en)	1994-06-23
KR100188572B1 (ko)	1999-06-01
FR2698791B1 (fr)	1995-09-15
SE9304080L (sv)	1994-06-10
GB2273442B (en)	1996-07-03
SE506496C2 (sv)	1997-12-22
AU674710B2 (en)	1997-01-09
SE9304080D0 (sv)	1993-12-08
NO934472D0 (no)	1993-12-08
JP2912537B2 (ja)	1999-06-28
IT1265258B1 (it)	1996-10-31
GB2273442A (en)	1994-06-22
FI935499A0 (fi)	1993-12-08
CA2111036A1 (en)	1994-06-10

Legal Events

Date	Code	Title	Description
2012-08-10	MM	Patent lapsed

Publication	Publication Date	Title
FI104362B (fi)	2000-01-14	Menetelmä uutteen valmistamiseksi cucurbita sp. -kasvin siemenistä
EP2364158B2 (en)	2016-03-23	Phytocomplex from bergamot fruit, process of manufacture and use as dietary supplement and in the pharmaceutical field
EP2162145B1 (en)	2016-05-04	Novel compounds and pharmaceutical preparations from neobeguea spec
US20100040758A1 (en)	2010-02-18	Integrated production of phytochemical rich plant products or isolates from green vegetation
DE60200895T2 (de)	2005-09-01	Verfahren zur Herstellung von reinen Phosphatiden und deren Verwendung in der Kosmetik, im pharmazeutischen Gebiet und im Bereich der Nahrungsmittel
EP1014927A1 (fr)	2000-07-05	Utilisation des shogaols et des gingerols pour la preparation de compositions deodorantes
JPH023495A (ja)	1990-01-09	抗酸化剤
KR20130051142A (ko)	2013-05-20	자소엽 추출물을 포함하는 뇌신경질환 예방 또는 치료용 의약 조성물
WO2011043212A1 (ja)	2011-04-14	セラミド産生促進剤及び保湿剤
US10967027B2 (en)	2021-04-06	Extracts of Cyclanthera pedata and formulations and uses thereof
EP2132994B1 (de)	2010-05-26	Fermentation von Granatapfelsaft-haltigen Lösungen durch Saccharomyces boulardii und Lactobacillen, daraus erhältliche Fermentationsprodukte und deren Verwendung
Pullaiah	2022	Forskolin
US7101913B2 (en)	2006-09-05	Hepatic disorder suppressant
JP2004137218A (ja)	2004-05-13	脂肪分解促進剤ならびにそれを用いた皮膚外用剤および飲食物
JP2003500346A (ja)	2003-01-07	皮膚美白剤
JP4105498B2 (ja)	2008-06-25	アトピー性疾患の症状の予防・緩和に有効な組成物
JP2017141204A (ja)	2017-08-17	ＮＦ−κＢ抑制作用を呈するグランジフロル酸誘導体及びその製造方法
KR20050097698A (ko)	2005-10-10	감 껍질을 이용한 올레아놀산 및 우르솔산의 제조방법
JP2000247880A (ja)	2000-09-12	脂肪分解促進剤
KR20020025358A (ko)	2002-04-04	발모 조성물 및 이의 제조 방법
WO2018212147A1 (ja)	2018-11-22	肌くすみ抑制剤及び肌バリア機能維持又は改善剤
EP3607959A1 (en)	2020-02-12	Formulations containing lipophilic extracts of spicy edible plants useful in controlling pain and inflammation
KARAGOZ et al.	2022	ACTIVE COMPOUND OF PISTACHIO
JP2025532437A (ja)	2025-09-30	ニームの木の葉の抽出物
WO2010088897A2 (de)	2010-08-12	Pflanzen-extrakte zur regulation des körpergewichtes